-

Haleon Recognized by Fast Company as a 2025 Brands That Matter Honoree

  • Haleon earns distinction in the Family of Brands category for building enduring trust and consumer connection
  • Award highlights Haleon’s leadership in purposeful innovation and consumer impact

WARREN, N.J.--(BUSINESS WIRE)--Haleon, a global leader in consumer health, today announced it has been honored in Fast Company’s 2025 Brands That Matter list in the Family of Brands category, which highlights companies that created cultural moments for multiple brands across their portfolios. The annual list recognizes organizations that demonstrate cultural relevance, meaningful consumer connection, and a clear commitment to purpose.

“We are incredibly proud to be recognized by Fast Company for the strength and impact of our brand portfolio,” said Katie Williams, U.S. Chief Marketing Officer at Haleon. “Our brands are trusted by people around the world, and this honor reflects our commitment to delivering science-backed products, transparent communication, and meaningful initiatives that support everyday health. At Haleon, we believe that helping people make better, more informed decisions about their health is not only our responsibility – it’s our purpose.”

Why this matters
Haleon’s diverse portfolio includes some of the world’s most recognized consumer health brands that are found in medicine cabinets across the globe – each with strong, distinct brand identities that resonate deeply with consumers, including Sensodyne, Centrum, Advil, Voltaren, Emergen-C, and Theraflu. Across the portfolio of brands, Haleon embeds insights-driven innovation, consumer education, and partnerships that not only meets consumer needs but also enriches the cultural conversations surrounding wellness, resilience, and informed self-care.

Haleon’s recognition in the Family of Brands category underscores the company’s ability to unite a diverse global portfolio under a shared mission – to put better everyday health in more hands. Through science-backed product innovations, consistent communications, cross-brand collaboration, and an unwavering focus on consumer wellbeing, Haleon’s brands have established deep emotional resonance and trust with individuals and families worldwide.

About Haleon
Haleon (NYSE: HLN) is a leading global consumer health company with a purpose to deliver better everyday health with Humanity. Haleon’s product portfolio spans six major categories: Oral Health, Pain Relief, Respiratory Health, Digestive Health, Wellness, and Sexual Wellness. Built on trusted science, innovation, and deep human understanding, Haleon’s U.S. brands include Abreva, Advil, Benefiber, Centrum, Emergen-C, Eroxon, Excedrin, Flonase, Gas-X, Nexium, Nicorette, Parodontax, Polident, Preparation H, Pronamel, Sensodyne, Robitussin, Theraflu, TUMS, Voltaren, and more. For more information on Haleon and its brands, please visit www.haleon.com or contact USMediaRelations@haleon.com.

For more information, please visit www.haleon.com

About Fast Company
Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies, and thinkers on the future of business. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, along with fellow business publication Inc. For more information, please visit fastcompany.com.

Contacts

Media Contacts
Kelly Gramuglia
kelly.x.gramuglia@haleon.com
908-632-3389

Industry:

Haleon

NYSE:HLN
Release Versions
English

Contacts

Media Contacts
Kelly Gramuglia
kelly.x.gramuglia@haleon.com
908-632-3389

More News From Haleon

Advil Challenges Sports Culture’s “No Pain No Gain” Mentality This Summer

WARREN, N.J.--(BUSINESS WIRE)--Today, Advil announced the launch of Rewriting Pain, a new initiative that challenges the narrative around pain in sports and encourages people to rethink what real strength looks like. As global attention turns to soccer this summer, Advil is stepping into the conversation with a clear message: it’s time to rethink the long-held idea that playing through pain is a sign of strength. Centered on the idea that pain should be confronted, not ignored, the campaign cha...

Haleon Issues Voluntary Nationwide Recall of Gas-X Extra Strength Softgels 125mg, 120 ct. and 72 ct.

WARREN, N.J.--(BUSINESS WIRE)--Haleon (NYSE: HLN) is voluntarily recalling four lots of Gas-X Extra Strength Softgels 125mg, 120 ct. and 72 ct. distributed on or about April 13, 2026 to the consumer level. The lots are being recalled due to potential contamination with a diluted propylene glycol-based coolant from a machine leakage during the packaging process. There is a potential that ingestion of the Softgels contaminated with the diluted propylene glycol-based coolant may result in adverse...

Haleon Appoints Richard Manso as US Chief Marketing Officer to Advance Data-driven, Consumer-centric Marketing in Delivering Better Everyday Health

WARREN, N.J.--(BUSINESS WIRE)--Today Haleon (NYSE: HLN), the consumer company that is solely focused on better everyday health, announced the appointment of Richard Manso as US Chief Marketing Officer, effective April 27, 2026. In this role, Manso will partner closely with CEO, US & President, North America Nathalie Gerschtein and the US leadership team to accelerate Haleon’s evolution into a more agile, consumer-centric organization. Manso will lead Haleon’s integrated US marketing organiz...
Back to Newsroom